Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Larimar Therapeutics
Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
September 29, 2026
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
August 4, 2026
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
May 14, 2026
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
April 30, 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
February 25, 2026